Company Quick10K Filing
Fabrinet
10-Q 2020-12-25 Filed 2021-02-02
10-Q 2020-09-25 Filed 2020-11-03
10-K 2020-06-26 Filed 2020-08-18
10-Q 2020-03-27 Filed 2020-05-05
10-Q 2019-12-27 Filed 2020-02-04
10-Q 2019-09-27 Filed 2019-11-05
10-K 2019-06-28 Filed 2019-08-20
10-Q 2019-03-29 Filed 2019-05-07
10-Q 2018-12-28 Filed 2019-02-05
10-Q 2018-09-28 Filed 2018-11-06
10-K 2018-06-29 Filed 2018-08-22
10-Q 2018-03-30 Filed 2018-05-08
10-Q 2017-12-29 Filed 2018-02-07
10-Q 2017-09-29 Filed 2017-11-07
10-K 2017-06-30 Filed 2017-08-23
10-Q 2017-03-31 Filed 2017-05-09
10-Q 2016-12-30 Filed 2017-02-07
10-Q 2016-09-30 Filed 2016-11-09
10-K 2016-06-24 Filed 2016-08-17
10-Q 2016-03-25 Filed 2016-05-03
10-Q 2015-12-25 Filed 2016-02-02
10-Q 2015-09-25 Filed 2015-11-03
10-K 2015-06-26 Filed 2015-08-19
10-Q 2015-03-27 Filed 2015-05-05
10-Q 2014-12-26 Filed 2015-02-03
10-Q 2014-09-26 Filed 2014-11-05
10-K 2014-06-27 Filed 2014-10-16
10-Q 2014-03-28 Filed 2014-05-06
10-Q 2013-12-27 Filed 2014-02-04
10-Q 2013-09-27 Filed 2013-11-05
10-K 2013-06-28 Filed 2013-08-16
10-Q 2013-03-29 Filed 2013-05-03
10-Q 2012-12-28 Filed 2013-02-05
10-K 2012-06-29 Filed 2012-08-28
10-Q 2012-03-30 Filed 2012-05-09
10-Q 2011-12-30 Filed 2012-02-08
10-Q 2011-09-30 Filed 2011-11-09
10-K 2011-06-24 Filed 2011-08-31
10-Q 2011-03-25 Filed 2011-05-04
10-Q 2010-12-24 Filed 2011-02-02
10-Q 2010-09-24 Filed 2010-11-03
10-K 2010-06-25 Filed 2010-09-08
8-K 2021-02-01 Earnings, Exhibits
8-K 2020-12-10 Shareholder Vote
8-K 2020-11-02
8-K 2020-08-11
8-K 2020-05-04
8-K 2020-02-01
8-K 2019-12-12
8-K 2019-11-04
8-K 2019-08-20
8-K 2019-08-19
8-K 2019-08-14
8-K 2019-05-01
8-K 2019-02-26
8-K 2019-02-04
8-K 2018-12-13
8-K 2018-08-14
8-K 2018-06-15
8-K 2018-06-04
8-K 2018-05-03
8-K 2018-02-05
8-K 2018-01-09

Fabrinet Financials

FN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546 323 0 0 0 0 -854
1 800 Flowers Com (FLWS) 944 42% 13.3 6% 665 336 1,266 534 37 75 1,001
10x Genomics (TXG) 4,805 75% -490.3 -2% 573 151 61 46 -10 -9 4,357
12 Retech (RETC) 0 32% -0.1 -1,385% 1 20 1 0 -15 -15 1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 34 0% 0.4 -5% 164 108 18 0 -8 -8 -3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 19 23 27 7 -3 -1 3
1895 Bancorp of Wisconsin (BCOW) 46,153 12,508.1 -0% 441 383 0 0 -0 4 46,142
1st Constitution Bancorp (FCCY) 165 0% 4.4 1% 1,343 1,204 0 0 14 33 144
1st Franklin Financial (FFC) 4 -0.6 7% 905 645 0 0 62 80 -46
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200 7.9 1% 6,691 5,858 0 0 70 136 1,073
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 2 0 0 -2 -2 0
21Vianet Group (VNET) 6,005 0% 11,151 5,788 0 0 0 0 3,344
22nd Century (XXII) 302 1% -14.1 -36% 62 7 26 0 -22 -21 302
1Life Healthcare (ONEM)

Balance Sheet ($MM)2011-09-302011-12-302012-03-302012-06-292012-09-302012-12-282013-03-292013-06-282013-09-272013-12-272014-03-282014-06-272014-09-262014-12-262015-03-272015-06-262015-09-252015-12-252016-03-252016-06-242016-09-302016-12-302017-03-312017-06-302017-09-292017-12-292018-03-302018-06-292018-09-282018-12-282019-03-292019-06-282019-09-27
Cash1321121251161151281571501641802342332451121291139513112814310686137137115138146161220231166188198
Accounts Receivable12298118128138131123118126122118101108104120135140147172196213241251264275259244247259262265261274
Inventory1071039910311110094899597108125129128127131143141150181205214225239255239240258278278285294322
PP&E83889616198989817097979916798106134223144159160276206214216339218223222364217212209382212
Assets4564134534614774714894654905045685655896016456736887247698569019461,0051,0331,0451,0381,0551,0881,1481,1761,2111,2551,290
Accounts Payable865775869274747790881029510299103115118115146172180187210215204182193220249248256258252
Long-Term Debt393634312926242261
Liabilities137126211211209185180140144139153138150151181194204217238302316326356352337316319347382374382392399
Stockholders' Equity318287243251268286309325346365415427440450464479484506531554585620649682707722736741766802829863891
Income Statement ($MM)2011-09-302011-12-302012-03-302012-06-292012-09-302012-12-282013-03-292013-06-282013-09-272013-12-272014-03-282014-06-272014-09-262014-12-262015-03-272015-06-262015-09-252015-12-252016-03-252016-06-242016-09-302016-12-302017-03-312017-06-302017-09-292017-12-292018-03-302018-06-292018-09-282018-12-282019-03-292019-06-282019-09-27
Revenue18697139143159167156160172195168160189210189206216233251276332351367370357337332345377403399405399
Cost of Revenue16388124128141166139143153172150142169186168182190205220243292308323326317300295306337358352359353
Gross Profit23915151821161719231718212122252628313440434445403737394046474746
R&D
SG&A75756675777791210111214121216181715161312171413141416
Tax1-2-0-012101-111111111222221221-121112
Net Income16-33-46716792115191548101191113220212023252227211921232832293326
Cash Flow ($MM)2011-09-302011-12-302012-03-302012-06-292012-09-302012-12-282013-03-292013-06-282013-09-272013-12-272014-03-282014-06-272014-09-262014-12-262015-03-272015-06-262015-09-252015-12-252016-03-252016-06-242016-09-302016-12-302017-03-312017-06-302017-09-292017-12-292018-03-302018-06-292018-09-282018-12-282019-03-292019-06-282019-09-27
Cash Operating10-1910261233-3181922816151012519186-1214111-340533536423
Cash Investing-8-12-8-9-43-3-2-1-335-4-1-146-22-26-201-16-4-47-373-10-12-9-2837-92-1912
Cash Financing31111-2-2-2-2-2-21-2-5-3-129-2-116-5131007-4-7-9-16-13-8-1-4